Skyward Specialty Insurance Group, Inc.
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets as of and (unaudited)
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| ($ in thousands, except share and per share amounts) · (Unaudited) | ||
| Assets | ||
| Investments: | ||
| Fixed maturity securities, available-for-sale, at fair value (net of allowance for credit losses of $7,000 and $0, respectively) (amortized cost of $1,800,068 and $1,320,266, respectively) | $1,805,218 | $1,292,218 |
| Fixed maturity securities, held-to-maturity, at amortized cost (net of allowance for credit losses of $236 and $243, respectively) | 34,568 | 39,153 |
| Equity securities, at fair value | 1,182 | 106,254 |
| Mortgage loans, at fair value | 9,998 | 26,490 |
| Equity method investments | 85,368 | 98,594 |
| Other long-term investments | 50,078 | 33,182 |
| Short-term investments, at fair value | 247,376 | 274,929 |
| Total investments | 2,233,788 | 1,870,820 |
| Cash and cash equivalents | 160,068 | 121,603 |
| Restricted cash | 38,197 | 35,922 |
| Premiums receivable, net | 583,148 | 321,641 |
| Reinsurance recoverables, net | 923,406 | 857,876 |
| Ceded unearned premium | 276,354 | 203,901 |
| Deferred policy acquisition costs | 144,932 | 113,183 |
| Deferred income taxes | 28,022 | 30,486 |
| Goodwill and intangible assets, net | 88,417 | 87,348 |
| Other assets | 117,714 | 86,698 |
| Total assets | $4,594,046 | $3,729,478 |
| Liabilities and stockholders’ equity | ||
| Liabilities: | ||
| Reserves for losses and loss adjustment expenses | $2,061,774 | $1,782,383 |
| Unearned premiums | 885,669 | 637,185 |
| Deferred ceding commission | 50,995 | 40,434 |
| Reinsurance and premium payables | 276,750 | 177,070 |
| Funds held for others | 123,304 | 102,665 |
| Accounts payable and accrued liabilities | 114,570 | 76,206 |
| Notes payable | 100,000 | 100,000 |
| Subordinated debt, net of debt issuance costs | 19,561 | 19,536 |
| Total liabilities | 3,632,623 | 2,935,479 |
| Stockholders’ equity | ||
| Common stock, $0.01 par value, 500,000,000 shares authorized, 40,487,365 and 40,127,908 shares issued and outstanding, respectively | 405 | 401 |
| Additional paid-in capital | 727,561 | 718,598 |
| Accumulated other comprehensive income (loss) | 9,539 | (22,120) |
| Retained earnings | 223,918 | 97,120 |
| Total stockholders’ equity | 961,423 | 793,999 |
| Total liabilities and stockholders’ equity | $4,594,046 | $3,729,478 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME (UNAUDITED)
| Three months ended September 30, | Nine months ended September 30, | |||
|---|---|---|---|---|
| ($ in thousands, except share and per share amounts) | 2025 | 2024 | 2025 | 2024 |
| Revenues: | ||||
| Net earned premiums | $351,797 | $269,557 | $947,705 | $763,482 |
| Commission and fee income | 1,904 | 1,818 | 6,440 | 5,897 |
| Net investment income | 22,180 | 19,535 | 60,107 | 59,866 |
| Net investment gains | 6,881 | 10,173 | 16,920 | 16,755 |
| Other loss | (236) | (195) | (216) | (202) |
| Total revenues | 382,526 | 300,888 | 1,030,956 | 845,798 |
| Expenses: | ||||
| Losses and loss adjustment expenses | 213,780 | 170,521 | 582,351 | 473,489 |
| Underwriting, acquisition and insurance expenses | 101,676 | 79,817 | 273,823 | 226,270 |
| Interest expense | 1,919 | 2,229 | 5,629 | 7,405 |
| Amortization expense | 455 | 351 | 1,164 | 1,099 |
| Other expenses | 4,149 | 1,117 | 6,212 | 3,350 |
| Total expenses | 321,979 | 254,035 | 869,179 | 711,613 |
| Income before income taxes | 60,547 | 46,853 | 161,777 | 134,185 |
| Income tax expense | 14,646 | 10,185 | 34,979 | 29,763 |
| Net income | $45,901 | $36,668 | $126,798 | $104,422 |
| Comprehensive income | ||||
| Net income | $45,901 | $36,668 | $126,798 | $104,422 |
| Other comprehensive income: | ||||
| Unrealized gains and losses on investments: | ||||
| Net change in unrealized gains on investments, net of tax | 6,740 | 31,396 | 30,000 | 24,527 |
| Reclassification adjustment for gains (losses) on securities no longer held, net of tax | 5,465 | (1,963) | 1,659 | (3,277) |
| Total other comprehensive income | 12,205 | 29,433 | 31,659 | 21,250 |
| Comprehensive income | $58,106 | $66,101 | $158,457 | $125,672 |
| Per share data: | ||||
| Basic earnings per share | $1.13 | $0.91 | $3.14 | $2.61 |
| Diluted earnings per share | $1.10 | $0.89 | $3.03 | $2.53 |
| Weighted-average common shares outstanding | ||||
| Basic | 40,487,069 | 40,098,345 | 40,377,864 | 40,039,269 |
| Diluted | 41,868,449 | 41,428,557 | 41,784,976 | 41,302,108 |
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)
| Three months ended September 30, | ||
|---|---|---|
| ($ in thousands, except share amounts) | 2025 | 2024 |
| Common shares: | ||
| Balance at beginning of period | 40,486,656 | 40,096,132 |
| Issuance of shares | 709 | 3,799 |
| Balance at September 30 | 40,487,365 | 40,099,931 |
| Common stock: | ||
| Balance at beginning of period | $405 | $401 |
| Issuance of common stock | — | — |
| Balance at September 30 | $405 | $401 |
| Additional paid-in capital: | ||
| Balance at beginning of period | $724,159 | $713,542 |
| Issuance of common stock | 3,402 | 2,553 |
| Balance at September 30 | $727,561 | $716,095 |
| Stock notes receivable: | ||
| Balance at beginning of period | $— | $(5,233) |
| Employee equity transactions | — | 5,233 |
| Balance at September 30 | $— | $— |
| Accumulated other comprehensive income (loss): | ||
| Balance at beginning of period | $(2,666) | $(31,136) |
| Other comprehensive income, net of tax | 12,205 | 29,433 |
| Balance at September 30 | $9,539 | $(1,703) |
| Retained earnings: | ||
| Balance at beginning of period | $178,017 | $46,046 |
| Net income | 45,901 | 36,668 |
| Balance at September 30 | $223,918 | $82,714 |
| Total stockholders’ equity | $961,423 | $797,507 |
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)
| Nine months ended September 30, | ||
|---|---|---|
| ($ in thousands, except share amounts) | 2025 | 2024 |
| Common shares: | ||
| Balance at beginning of year | 40,127,908 | 39,863,756 |
| Issuance of shares | 359,457 | 236,175 |
| Balance at September 30 | 40,487,365 | 40,099,931 |
| Common stock: | ||
| Balance at beginning of year | $401 | $399 |
| Issuance of common stock | 4 | 2 |
| Balance at September 30 | $405 | $401 |
| Additional paid-in capital: | ||
| Balance at beginning of year | $718,598 | $710,855 |
| Issuance of common stock | 8,963 | 5,240 |
| Balance at September 30 | $727,561 | $716,095 |
| Stock notes receivable: | ||
| Balance at beginning of year | $— | $(5,562) |
| Employee equity transactions | — | 5,562 |
| Balance at September 30 | $— | $— |
| Accumulated other comprehensive income (loss): | ||
| Balance at beginning of year | $(22,120) | $(22,953) |
| Other comprehensive income, net of tax | 31,659 | 21,250 |
| Balance at September 30 | $9,539 | $(1,703) |
| Retained earnings (accumulated deficit): | ||
| Balance at beginning of year | $97,120 | $(21,708) |
| Net income | 126,798 | 104,422 |
| Balance at September 30 | $223,918 | $82,714 |
| Total stockholders’ equity | $961,423 | $797,507 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.